Cardiología

  • Bibliografía Cardiología (actualizado a 21 abril - 33 referencias)



  1. Wei J, Xu H, Xiong J, Shen Q, Fan B, Ye C, et al. 2019 Novel Coronavirus (COVID-19) Pneumonia: Serial Computed Tomography Findings. Korean J Radiol. 2020;21(4):501.

  2. Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM), Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Med Res. diciembre de 2020;7(1):4.

  3. He H, Zhao S, Han L, Wang Q, Xia H, Huang X, et al. Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Syndrome Coronavirus-2 Infection. Journal of Cardiothoracic and Vascular Anesthesia. marzo de 2020;S1053077020302706.

  4. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol [Internet]. 25 de marzo de 2020 [citado 21 de abril de 2020]; Disponible en: https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524

  5. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol [Internet]. 27 de marzo de 2020 [citado 21 de abril de 2020]; Disponible en: https://jamanetwork.com/journals/jamacardiology/fullarticle/2763843

  6. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Progress in Cardiovascular Diseases. marzo de 2020;S0033062020300554.

  7. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. Journal of the American College of Cardiology. marzo de 2020;S0735109720346374.

  8. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol [Internet]. 27 de marzo de 2020 [citado 21 de abril de 2020]; Disponible en: https://jamanetwork.com/journals/jamacardiology/fullarticle/2763845

  9. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. Journal of the American College of Cardiology. marzo de 2020;S0735109720345666.

  10. He Y, Wei J, Bian J, Guo K, Lu J, Mei W, et al. Chinese Society of Anesthesiology Expert Consensus on Anesthetic Management of Cardiac Surgical Patients With Suspected or Confirmed Coronavirus Disease 2019. Journal of Cardiothoracic and Vascular Anesthesia. marzo de 2020;S1053077020302755.

  11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 17 de marzo de 2020;323(11):1061.

  12. Pasquale GD. Coronavirus COVID-19: quali implicazioni per la Cardiologia? G Ital Cardiol (Rome). 2020;21(4):243-5.

  13. Canadian Cardiovascular Society, CHFS/SCIC. COVID-19 and concerns regarding use of ACEi_ARB_ARNi medications for heart failure or hypertension [Internet]. 2020 [citado 21 de abril de 2020]. Disponible en: https://www.ccs.ca/images/Images_2020/CCS_CHFS_statement_regarding_COVID_EN.pdf

  14. Akhmerov A, Marban E. COVID-19 and the Heart. Circulation Research. 7 de abril de 2020;CIRCRESAHA.120.317055.

  15. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. Journal of the American College of Cardiology. abril de 2020;S0735109720350087.

  16. Canadian Cardiovascular Society. COVID-19 et maladies cardiovasculaires : ce que le fournisseur de soins de santé cardiaque doit savoir [Internet]. 2020 [citado 21 de abril de 2020]. Disponible en: https://www.ccs.ca/images/Images_2020/COVID_and_Cardiovascular_Disease_22Mar2020_FR.pdf

  17. Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap! Circulation. 14 de abril de 2020;CIRCULATIONAHA.120.047293.

  18. Liang ZC, Ooi SBS. COVID‐19: A Singapore Orthopedic Resident’s Musings in the Emergency Department. Zink B, editor. Acad Emerg Med. abril de 2020;27(4):349-50.

  19. Han Y, Zeng H, Jiang H, Yang Y, Yuan Z, Cheng X, et al. CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic. Circulation. 27 de marzo de 2020;CIRCULATIONAHA.120.047011.

  20. Ñamendys-Silva SA. ECMO for ARDS due to COVID-19. Heart & Lung. marzo de 2020;S014795632030100X.

  21. Lakkireddy DR, Chung MK, Gopinathannair R, Patton KK, Gluckman TJ, Turagam M, et al. Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Heart Rhythm. abril de 2020;S1547527120302897.

  22. Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, Martín-Moreiras J, Ramón Rumoroso J, López-Palop R, et al. Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiología intervencionista en España. RECIC. 17 de abril de 2020;4059.

  23. Huang Z, Jiang Y, Chen J, Zhou Y. Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19. Cardiol J. 14 de abril de 2020;

  24. Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System—a Call for Epidemiologic Investigations. Clinical Infectious Diseases. 26 de marzo de 2020;ciaa329.

  25. Lin X, Gong Z, Xiao Z, Xiong J, Fan B, Liu J. Novel Coronavirus Pneumonia Outbreak in 2019: Computed Tomographic Findings in Two Cases. Korean J Radiol. 2020;21(3):365.

  26. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol [Internet]. 27 de marzo de 2020 [citado 21 de abril de 2020]; Disponible en: https://jamanetwork.com/journals/jamacardiology/fullarticle/2763846

  27. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol [Internet]. 11 de marzo de 2020 [citado 21 de abril de 2020]; Disponible en: http://link.springer.com/10.1007/s00392-020-01626-9

  28. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz [Internet]. 5 de marzo de 2020 [citado 21 de abril de 2020]; Disponible en: http://link.springer.com/10.1007/s00059-020-04909-z

  29. Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, et al. SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? European Heart Journal. 20 de marzo de 2020;ehaa235.

  30. Huang L, Lin G, Tang L, Yu L, Zhou Z. Special attention to nurses’ protection during the COVID-19 epidemic. Crit Care. diciembre de 2020;24(1):120, s13054-020-2841-7.

  31. AlGhatrif M, Cingolani O, Lakatta EG. The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science. JAMA Cardiol [Internet]. 3 de abril de 2020 [citado 21 de abril de 2020]; Disponible en: https://jamanetwork.com/journals/jamacardiology/fullarticle/2764300

  32. Elkind MSV, Harrington RA, Benjamin IJ. The Role of the American Heart Association in the Global COVID-19 Pandemic. Circulation [Internet]. 14 de abril de 2020 [citado 21 de abril de 2020];141(15). Disponible en: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.046749

  33. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clinica Chimica Acta. julio de 2020;506:145-8.